Last $23.86 USD
Change Today -0.14 / -0.58%
Volume 1.7M
IDIX On Other Exchanges
Symbol
Exchange
IDIX is not on other exchanges.
As of 8:10 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ronald C. Renaud Jr.

Chief Executive Officer, President and Director, Idenix Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 40 board members in 2 different organizations across 5 different industries.

See Board Relationships
45$2,272,527
As of Fiscal Year 2013

Background*

Mr. Ronald C. Renaud, Jr., also known as Ron, has been the Chief Executive Officer and President of Idenix Pharmaceuticals Inc. since October 28, 2010. Mr. Renaud has been Principal and Equity Research Analyst of SoundView Technology Group Inc. since September 2003. Mr. Renaud served as the Chief Financial Officer of Idenix Pharmaceuticals Inc., from June 29, 2007 to October 28, 2010, its Chief Business Officer from June 2010 to October 28, 2010, and also served as its ...

Read Full Background

Corporate Headquarters*

320 Bent Street
Cambridge, Massachusetts 02141

United States

Phone: 617-995-9800
Fax: 617-995-9801

Board Members Memberships*

2010-Present
Chief Executive Officer, President and Director
2014-Present
Director

Education*

MBA
University of Southern California, Marshall School of Business
BA
Saint Anselm College

Other Affiliations*

Annual Compensation*

Salary$546,154
Total Annual Compensation$546,154

Stock Options*

All Other Compensation$8,723
Exercisable Options1,226,885
Exercisable Options Value$1,503,849
Unexercisable Options728,125
Unexercisable Options Value$860,687
Total Value of Options$2,364,535
Total Number of Options1,955,010

Total Compensation*

Total Annual Cash Compensation$769,877
Total Short Term Compensation$546,154
Other Long Term Compensation$8,723
Total Calculated Compensation$2,272,527
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IDIX:US $23.86 USD -0.14

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IDENIX PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.